These discussions help patients make informed decisions about whether to continue or adjust their GLP-1 regimen
Supply Side Stakeholders: Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants Demand Side Stakeholders: Stakeholders in Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, Hospitals & Clinics, Hospital Pharmacies, and Retail & Online Pharmacies
Lipo C injections are unlicensed compounded preparations not approved by the MHRA, meaning they are not subject to the same quality, safety, and efficacy standards as licensed medicines
Below is a tiny sample of Reddit and Facebook threads that capture common themes from patients and clinicians navigating long term GLP-1 use: Closing Thoughts Long term use and discontinuing GLP-1s is unlikely to follow a single, uniform pathway